Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Operating Leases (2021 - 2025)

Historic Operating Leases for HeartSciences (HSCS) over the last 5 years, with Q4 2025 value amounting to $247263.0.

  • HeartSciences' Operating Leases fell 3428.07% to $247263.0 in Q4 2025 from the same period last year, while for Oct 2025 it was $247263.0, marking a year-over-year decrease of 3428.07%. This contributed to the annual value of $314527.0 for FY2025, which is 2753.59% down from last year.
  • Latest data reveals that HeartSciences reported Operating Leases of $247263.0 as of Q4 2025, which was down 3428.07% from $281570.0 recorded in Q3 2025.
  • HeartSciences' Operating Leases' 5-year high stood at $549227.0 during Q4 2022, with a 5-year trough of $90968.0 in Q2 2022.
  • Moreover, its 5-year median value for Operating Leases was $405743.0 (2024), whereas its average is $379900.7.
  • As far as peak fluctuations go, HeartSciences' Operating Leases skyrocketed by 48958.64% in 2023, and later plummeted by 3428.07% in 2025.
  • Over the past 5 years, HeartSciences' Operating Leases (Quarter) stood at $107632.0 in 2021, then surged by 410.28% to $549227.0 in 2022, then fell by 11.35% to $486885.0 in 2023, then fell by 22.72% to $376241.0 in 2024, then crashed by 34.28% to $247263.0 in 2025.
  • Its Operating Leases was $247263.0 in Q4 2025, compared to $281570.0 in Q3 2025 and $314527.0 in Q2 2025.